SAN FRANCISCO (MarketWatch) � Barnes & Noble Inc. is the latest U.S. company to consider going private, helping the stock to rally by double digits on Monday.
GainersAmgen Inc. AMGN �shares rose 4%, leading the gainers in the S&P 500 SPX . The company is expected to benefit in the short term from Affymax�s Omontys recall, said Boris Peaker, an analyst at Oppenheimer.
Barnes & Noble Nook tablet.Barnes & Noble Inc. BKS �shares gained 11%. The company said Monday that it received a proposal from founder, largest shareholder and board chairman Leonard Riggio to buy Barnes & Noble�s retail business and that it is evaluating the plan. See: Barnes & Noble�s founder considering buyout proposal
U.S.-listed shares of Elan Corp. PLC ELN �gained more than 7%. Royalty Pharma Management LLC on Monday said it had made an $11-per-share indicative bid for Elan, which has not yet formally responded. See: Royalty Pharma Management mulls $11-a-share bid for Elan
DeclinersAffymax Inc. AFFY shares tumbled more than 84%. Affymax and Takeda Pharmaceutical Co. TKPYY said on Sunday they recalled their antianemia drug Omontys after some patients with kidney disease suffered from strong allergic reactions and, in some cases, death.
Click to Play Protest vote looms on Italy resultsWSJ's Giada Zampano in Rome feels the pulse of Italian disaffected voters as they head to the polls for Italy's most-watched elections in decades.
Mead Johnson Nutrition Co. MJN shares slipped 4.1%, the worst in the S&P 500. The manufacturer of pediatric nutrition products said in a regulatory filing on Monday that authorities in Hong Kong are introducing restrictions on cross-border trading in formula with China. �Approximately 30% of Mead Johnson sales in the China/Hong Kong market originate in Hong Kong. It is believed that a substantial portion of the products sold in Hong Kong are taken to mainland China by visitors and private resellers,� said the company in the filing. Mead Johnson said it was not revising its earnings outlook as it is difficult to assess the potential net impact of the revision in regulation.
Top Tickers Trending$CME: CME Group Inc. CME �sparked conversation online. It approached Deutsche Boerse AG DE:DB1 �for merger talks, Bloomberg News reported on Monday. However, Deutsche Boerse said in a statement that it�s not in merger negotiations with CME Group, adding that its primary focus is on organic growth.
$LOW: Lowe�s Cos. LOW trended on Twitter. The home-improvement retailer said on Monday its fourth-quarter net income fell 11% to 26 cents a share, beating analysts� estimates of 23 cents a share. Shares rose about 2% in premarket trade. See: Lowe�s quarterly profit down, planning $5-billion buyback
No comments:
Post a Comment